Which risk model can better predict hepatocellular carcinoma in hepatitis B patients with an antiviral treatment duration of over 1 year?
- PMID: 37414258
- DOI: 10.1016/j.jhep.2023.06.014
Which risk model can better predict hepatocellular carcinoma in hepatitis B patients with an antiviral treatment duration of over 1 year?
Comment on
-
Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States.J Hepatol. 2022 Feb;76(2):294-301. doi: 10.1016/j.jhep.2021.09.009. Epub 2021 Sep 23. J Hepatol. 2022. PMID: 34563579 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
